Abstract
Abstract
Background
Coronavirus disease 2019 (COVID-19) was previously thought to have a low reinfection rate, but there are concerns that the reinfection rate will increase with the emergence and spread of mutant variants. This report describes the case of a 36-year-old, non-immunosuppressed man who was infected twice by two different variants of COVID-19 within a relatively short period.
Case presentation
A 36-year-old Japanese man with no comorbidities was infected with the E484K variant (R.1 lineage) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Symptoms were mild and improved with symptomatic treatment alone. About four months later he presented to another outpatient department with high fever and headache. We diagnosed him as infected with the Alpha variant (B.1.1.7) of SARS-CoV-2 based on SARS-CoV-2 real-time reverse transcription polymerase chain reaction testing (RT-PCR). The patient was hospitalized with high fever. The patient received treatment in the form of anti-inflammatory therapy with corticosteroid and antibacterial chemotherapy. The patient improved without developing severe disease.
Conclusion
Concerns have been raised that the reinfection rate of COVID-19 will increase with the emergence of mutant variants. Particularly in mild cases, adequate amounts of neutralizing antibodies may not be produced, and reinfection may thus occur. Continued attention to sufficient infection control is thus essential.
Publisher
Springer Science and Business Media LLC
Subject
General Earth and Planetary Sciences,General Environmental Science,Cell Biology,Developmental Biology,Embryology,Anatomy
Reference24 articles.
1. Wibmer CK, Avres F, Hermanus T et al (2021) SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma. Nat Med 27:622–625. https://doi.org/10.1038/s41591-021-01285-x
2. To KK, Hung IF, JD IP et al (2021) Coronavirus Disease 2019 (COVID-19) re-infection by a phylogenetically distinct severe acute respiratory syndrome coronavirus 2 strain confirmed by whole genome sequencing. Clin Infect Dis 73:e2946–e2951. https://doi.org/10.1093/cid/ciaa1275
3. COVID-19 Data Repository by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University. https://github.com/CSSEGISandData/COVID-19. Accessed 29 Oct 2022.
4. COVID-19 Information Page. National Institute of Infectious Disease, Japan. 2022. https://www.niid.go.jp/niid/ja/2019-ncov/2551-cepr/10900-sars-cov-2-b-1-1-530.html. Accessed 27 Sep 2022. In Japanese.
5. WHO. Weekly epidemiological update on COVID-19. 2021. https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19-4-may-2021. Accessed 29 Oct 2022.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献